Search Results
Feb 19, 2026, 07:15 ET DEXIS ADVANCES DIGITAL DENTISTRY WITH ENHANCED LAB-TO-CLINIC WORKFLOW SOLUTIONS
TikTok.DXIS01428 Rev00
More news about: DEXIS, LLC
Feb 19, 2026, 03:04 ET Truck Mounted Cranes Market to Reach USD 28.7B by 2036 (8.1% CAGR) | U.S., Germany & China Drive Modernization | 15-30 Ton Class Holds 38% Share
resilience. In February 2026, Terex Corporation merged with REV Group to form a larger specialty equipment manufacturer. As stated by Simon Meester, Terex President & Chief Executive Officer, "The combination with REV Group is a defining moment in Terex's transformation… The merger
More news about: Future Market Insights
Feb 18, 2026, 09:30 ET bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality
Europe.1 Snyder, A.B., Martin, N. & Wiedmann, M. Microbial food spoilage: impact, causative agents and control strategies. Nat Rev Microbiol 22, 528–542 (2024).
More news about: bioMérieux
Feb 17, 2026, 14:00 ET Ski-Doo Unveils New, Improved Features and Technologies to Make the Most Out of Winter
Key Highlights for 2027 Ski-Doo Lineup:Skandic and Tundra models move to the REV Gen5 platform with uMotion rear suspension for superior comfort and capability.Expedition LE model with best price and
More news about: BRP Inc.
Feb 17, 2026, 14:00 ET Ski-Doo Unveils New, Improved Features and Technologies to Make the Most Out of Winter
Key Highlights for 2027 Ski-Doo Lineup:Skandic and Tundra models move to the REV Gen5 platform with uMotion rear suspension for superior comfort and capability.Expedition LE model with best price and
More news about: BRP Inc.
Feb 13, 2026, 16:53 ET EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA® VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS
2025;392(12):1168-1177.Perugino CA, Stone JH. IgG4-bezogene Krankheit: Ein Update zur Pathophysiologie und Auswirkungen auf die klinische Versorgung. Nat Rev Rheumatol. 2020;16(12):702-714.Lazaridis K, Tzartos SJ. Autoantikörperspezifitäten bei Myasthenia gravis: Implikationen für verbesserte
More news about: Amgen
Feb 13, 2026, 14:41 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK UPLIZNA® OD SPOLOČNOSTI AMGEN NA LIEČBU GENERALIZOVANEJ MYASTÉNIE GRAVIS
(12): 1168-1177.Perugino CA, Stone JH. Ochorenie súvisiace s IgG4: aktualizácia patofyziológie a dôsledky pre klinickú starostlivosť. Nat Rev Rheumatol. 2020;16(12):702-714.Lazaridis K, Tzartos SJ. Špecificity autoprotilátok pri myasténii gravis: dôsledky pre zlepšenie diagnostiky
More news about: Amgen
Feb 13, 2026, 11:47 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN UPLIZNA ® ДЛЯ ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАННОЙ МИАСТЕНИИ
2025;392(12):1168-1177.Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702-714.Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis: implications for improved diagnostics
More news about: Amgen
Feb 13, 2026, 11:41 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK UPLIZNA® SPOLEČNOSTI AMGEN PRO GENERALIZOVANOU MYASTENII GRAVIS
2025;392(12):1168-1177.Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702-714.Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis: implications for improved
More news about: Amgen
Feb 13, 2026, 09:34 ET KOMISJA EUROPEJSKA ZATWIERDZA LEK UPLIZNA® FIRMY AMGEN W LECZENIU UOGÓLNIONEJ MIASTENII
pathophysiology and implications for clinical care (Choroba związana z IgG4: aktualizacja dotycząca patofizjologii i implikacji dla opieki klinicznej). Nat Rev Rheumatol. 2020;16(12):702-714.Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis: implications for improved diagnostics
More news about: Amgen
Feb 12, 2026, 15:30 ET LA COMMISSION EUROPEENNE APPROUVE UPLIZNA® D'AMGEN DANS LE CADRE DU TRAITEMENT DE LA MYASTHÉNIE GRAVE GÉNÉRALISÉE
2025;392(12):1168-1177.Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702-714.Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis: implications for improved diagnostics
More news about: Amgen
Feb 12, 2026, 15:15 ET La Comisión Europea aprueba UPLIZNA® de Amgen para la miastenia gravis generalizada
2025;392(12):1168-1177.Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702-714.Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis: implications for improved diagnostics
More news about: Amgen
Feb 12, 2026, 09:00 ET EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS
2025;392(12):1168-1177.Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702-714.Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis: implications for improved diagnostics
More news about: Amgen
Feb 11, 2026, 09:15 ET From Herbs to Harmonics: Doctah B Sirius Ushers in a New Era with What's Eating You, an Integrated Book and Medicine Music Healing Experience
potential through natural therapies and elevated consciousness.His teachings have been embraced by leading voices and cultural icons including Rev. Michael Bernard Beckwith, who wrote the book's forward, the late Dick Gregory, Iyanla Vanzant, Billy Carson, and legendary spiritual
More news about: Doctah B Sirius
Feb 11, 2026, 09:03 ET Stryker launches T2 Alpha Humerus Nailing System, supporting surgical workflow and care for complex fractures
[email protected] Report № D0000353370, Rev AA.Internal Report № D0000305724, Rev AA.Konda SR, Maseda M, et al. Observational prospective unblinded case-control study to evaluate
More news about: Stryker
Feb 11, 2026, 07:00 ET Terex Reports Fourth Quarter and Full-Year 2025 Results
merged businesses, including REV Group, Inc. ("REV"), and we may not realize the anticipated benefits of any merged or acquired business;we may be unable to effectively manage our expanded operations following the completion of the recent transaction with REV;potential divestitures
More news about: Terex Corporation
Feb 10, 2026, 10:30 ET Episcopal Relief & Development Received an $8 Million Grant to Expand Work to Reduce Violence Against Women and Girls
communities where women and girls can thrive.""The Muglia family has made a transformative investment in God's mission around the world," said the Most Rev. Sean W. Rowe, Presiding Bishop of The Episcopal Church. "This expression of Christian charity will enable Episcopal Relief & Development to significantly
More news about: Episcopal Relief & Development
Feb 10, 2026, 10:01 ET SPECTRUM PARTNERS WITH CARSON HOCEVAR, SPIRE MOTORSPORTS, FOR NASCAR CUP SERIES CAMPAIGN
Carson Hocevar. Spectrum will rev up as the team's primary sponsor for multiple NASCAR Cup Series races in 2026, beginning Sunday, February 15th with the 68th running of the Daytona 500
More news about: Charter Communications, Inc.
Feb 10, 2026, 09:05 ET TEREX COMPLETES SALE OF MIDWEST RECREATIONAL VEHICLE BUSINESS
Automotive Designs ("Midwest") to Alliance RV, LLC. Previously, Midwest operated within the Recreational Vehicles segment of REV Group. Terex recently completed its merger with REV Group.
More news about: Terex Corporation
Feb 10, 2026, 07:20 ET Firebird and U.S. Government Announce Phase 2 of Armenia AI Megaproject, Scaling it to $4 Billion and 50,000 GPU in 2026
visit to Yerevan by U.S. Vice President JD Vance, who disclosed the details at a press briefing alongside the Prime Minister of Armenia Nikol Pashinyan, Rev Lebaredian, Vice President of Omniverse and Simulation Technology at NVIDIA, and Firebird co-founders Razmig Hovaghimian and Alexander Yesayan.Prime
More news about: Firebird
Feb 06, 2026, 09:08 ET Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers' hands
World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–723. Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of Endocrinology
More news about: NOVO NORDISK INC.
Feb 06, 2026, 00:10 ET 雲頂新耀宣佈中國國家藥品監督管理局批准維適平®用於治療中重度潰瘍性結腸炎的新藥上市許可申請
30:S2468-1253(25)00198-0.[2] Shao B, et al. Front Public Health. 2022 Oct 25;10:1032679. [3] Kaplan GG. Nat Rev Gastroenterol Hepatol. 2015;12(12):720-727.[4] Sandborn WJ, et al. Lancet. 2023 Apr 8;401(10383):1159-1171.關於雲頂新耀
More news about: 雲頂新耀
Feb 05, 2026, 06:44 ET Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
[3] Sabari, J., Lok, B., Laird, J. et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol 14, 549–561 (2017).[4]
More news about: Henlius
Feb 04, 2026, 09:30 ET Nicklaus Children's Heart Institute Leads the Region with Groundbreaking Techniques for Congenital Heart Disorders
blood flow by enabling both ventricles of the heart to function effectively. Nicklaus Children's is among the few centers in the nation offering the REV operation, in which the cardiac surgical team corrects transposition of the great arteries with ventricular septal defect and pulmonary stenosis by rerouting
More news about: Nicklaus Children's Health System
Feb 02, 2026, 09:05 ET TEREX AND REV GROUP COMPLETE MERGER, CREATING A PREMIER SPECIALTY EQUIPMENT MANUFACTURER
regulations and their enforcement, and the degree of competition in the geographic and business areas in which REV and Terex operate; any failure to promptly and effectively integrate the businesses of REV and Terex; the possibility that the Transaction may be more expensive to complete than anticipated, including
More news about: Terex Corporation